Pearl Therapeutics Raises $15 Million
Pearl Therapeutics, a Redwood City, Calif.-based drug developer focused on respiratory disorders, has raised $15 million in Series C funding from return backers Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. It previously raised around $35.5 million, plus $8 million in venture debt.
1 February 2010•3 mins read
